Scope & Mission

Frontiers in Drug Discovery is an Open Access journal publishing rigorously peer-reviewed research across disciplines and associated cutting edge technologies that are critical to the discovery and development of new drugs and therapies. Field Chief Editor Bruno Villoutreix at INSERM is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide. The covered drugs encompass a wide variety of agents, including small molecules and biologics. 

Coverage includes:

• Small molecules including short peptides, nucleic acids, macrocycles
• Biologics including therapeutic proteins, antibodies, cell therapies
• Experimental low, medium and high-throughput approaches
• In vitro models for early-stage drug discovery such as 3D cell cultures, patient-derived organoids
• A broad range of in silico methods from molecular modeling to artificial intelligence
• Big data and smart data, knowledge discovery and actionable knowledge
• Novel targets, pathways and molecular mechanisms in the health and disease states
• Novel therapeutic strategies
• Drug repurposing
• Drug combination
• In silico and in vitro ADME-Tox studies to assist drug discovery
• Computational-Chemistry-Biology-Medicine continuum
• National and International Drug Discovery and Development Platforms and Networks
• Integration of skills and technologies, Transcending silo mentality and promoting efficiency 

We also welcome editorial submissions that explore topics such as personalized and stratified medicine, pharmacoeconomics, project mining, management and strategic planning, ecosystem mapping, public-private partnerships, academic drug discovery and translational medicine, training and education, empowering citizen and patients to contribute to the drug discovery process and increasing the awareness of politicians and mass medias about drug discovery

Frontiers in Drug Discovery is a member of the Committee on Publication Ethics.

Submission

Frontiers in Drug Discovery is composed of the following Specialty Sections:

Copyright Statement